Press Release: Affini-T : Affini-T Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

BOSTON--(BUSINESS WIRE)--Affini-T Therapeutics, Inc., a clinical stage biopharmaceutical company focused on the development of precision immunotherapies for treatment of patients with solid tumors, today announced that Jak Knowles, M.D., Co-founder, President and Chief Executive Officer, will present a company overview at the 43rd Annual J.P. Morgan Healthcare Conference on Thursday, January 16, 2025 at 10:30 a.m. PT in San Francisco, CA. Management will also participate in one-on-one meetings.